Figure 2From: Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites MDA recommendations for schistosomiasis and trachoma for the 21 sentinel sites from observed data on prevalence of the two diseases; low S. haematobium prevalence (< 10%) and low trachoma prevalence (< 10%) (white markers; no MDA recommended); low S. haematobium prevalence (< 10%) and high trachoma prevalence (> 10%) (yellow markers; MDA for trachoma is recommended); medium S. haematobium prevalence (10-49%) and high trachoma prevalence (> 10%) (red markers; MDA in school-aged children; community MDA for trachoma).Back to article page